The aim of this study is to assess the long-term performance and safety of HLS KneeTec cementless and hybrid fixation knee prosthesis when used in standard medical practice.
It is planned to collect prospective and retrospective data from a continuous and exhaustive series of patients in French sites where Total Knee Arthroplasty with HLS Kneetec cementless and hybrid fixation knee prosthesis is performed routinely All patients treated with HLS KneeTec (cementless or hybrid versions) implant will be included. All eligible patients seen in consultation and who agree to participate in the study should be included, systematically and consecutively, since the initiation of the study. Patients will be assessed according to the usual practice of the investigator at each participating site before surgery and then at the follow-up (FU) visits as following: 4 months (+/- 2 months); 1 year (+/- 2 months); 5 years (+/- 12 months) and 10 years (+/- 12 months).
Study Type
OBSERVATIONAL
Enrollment
163
patient with HLS KneeTec cementless and hybrid fixation prosthesis
Chu Angers
Angers, France
Clinique Du Parc
Caen, France
Centre Hospitalier Compiegne Noyon
Compiègne, France
Evaluation of implant survival in subjects receiving a total knee arthroplasty with the HLS KneeTec cementless and hybrid fixations up to 10 years after the surgery
Kaplan Meier survival rate up to 10 years after the surgery.
Time frame: 10-year
Evaluation of clinical performance of the HLS KneeTec cementless and hybrid fixations after the surgery
IKS score
Time frame: starting preoperatively up to 10 years
Evaluation of clinical performance of the HLS KneeTec cementless and hybrid fixations after the surgery
Oxford Knee Score
Time frame: 5 and 10 years
Radiographic analysis of the HLS KneeTec cementless and hybrid fixations at 4 months, 1, 5 and 10 years minimum
radiological analysis from immediate postoperative up to 10-year FU
Time frame: 4 months, 1, 5 and 10 years
Evaluation of safety performance during the surgery up to 10 years after the surgery
Number, severity and casual relationship of procedure or implant-related adverse events
Time frame: starting intraoperatively up to 10-year FU
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.